Vergoeding 2019-2023 voor ATC-subgroep R06AX : Overige antihistaminica voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| R06AX13 Loratadine (Hooikoortstablet loratadine htp ®) | 287.310 | 302.780 | 286.130 | 283.910 | 268.690 |
| R06AX17 Ketotifen (Zaditen ®) | 149.080 | 144.990 | 154.910 | 177.500 | 216.110 |
| R06AX18 Acrivastine (Semprex ®) | 175.580 | 198.600 | 201.550 | 182.040 | 166.760 |
| R06AX22 Ebastine (Kestine ®) | 279.280 | 274.590 | 250.480 | 255.500 | 224.710 |
| R06AX25 Mizolastine (Mizollen ®) | 550.440 | 578.930 | 572.320 | 565.320 | 556.290 |
| R06AX26 Fexofenadine (Telfast ®) | 1.889.800 | 1.814.400 | 1.950.000 | 2.683.400 | 2.645.700 |
| R06AX27 Desloratadine (Aerius ®) | 5.022.800 | 3.914.000 | 4.444.200 | 4.726.400 | 4.631.700 |
| R06AX28 Rupatadine (Rupafin ®) | 512.780 | 635.520 | 715.490 | 928.690 | 766.160 |
| Totaal | 8.867.070 | 7.863.810 | 8.575.080 | 9.802.760 | 9.476.120 |